Gut microbiota, probiotics and diabetes
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
Diabetes is a condition of multifactorial origin, involving several molecular mechanisms related to the intestinal microbiota for its development. In type 2 diabetes, receptor activation and recognition by microorganisms from the intestinal lumen may trigger inflammatory responses, inducing the phosphorylation of serine residues in insulin receptor substrate-1, reducing insulin sensitivity. In type 1 diabetes, the lowered expression of adhesion proteins within the intestinal epithelium favours a greater immune response that may result in destruction of pancreatic β cells by CD8+ T-lymphocytes, and increased expression of interleukin-17, related to autoimmunity. Research in animal models and humans has hypothesized whether the administration of probiotics may improve the prognosis of diabetes through modulation of gut microbiota. We have shown in this review that a large body of evidence suggests probiotics reduce the inflammatory response and oxidative stress, as well as increase the expression of adhesion proteins within the intestinal epithelium, reducing intestinal permeability. Such effects increase insulin sensitivity and reduce autoimmune response. However, further investigations are required to clarify whether the administration of probiotics can be efficiently used for the prevention and management of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The gut flora mediates three pathways connected to the pathogenesis of obesity and diabetes: low-grade inflammation, raised blood levels of lipopolysaccharides (endotoxemia), and increased energy harvest.”
From A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents. (2024) · cites this paper as [110]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Quirós et al. (76) found that kefir is able to inhibit the activity of angiotensin-converting enzyme (ACE) through the action of bioactive peptides generated from casein during the milk fermentation process.”
From Milk kefir : nutritional, microbiological and health benefits (2017) · cites this paper as [76]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Colonic flora, Probiotics, Obesity and Diabetes
Marik, P. E. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00087 · Cited by 38
RetractedHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 1×
“Studies have shown the intestinal microbiota is associated with the development of metabolic diseases, as obese and diabetic subjects present perturbations in the proportions of Firmicutes, Bacteroidetes and Proteobacterias [4,12].”
BackgroundInterleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“IL-10 is an anti-inflammatory cytokine which inhibits antigen presentation and proinflammatory cytokine production [107], whereas depletion of hepatic natural killer cells is linked to the development of hepatic insulin resistance [108].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 2×
“However, TLRs also stimulate adaptive immunity, once they induce the secretion of inflammatory cytokines [36].”
BackgroundInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 3×
“AGE: Advanced glycation end products; AKT: Protein kinase B; AP-1: Activating protein 1; BB: BioBreeding diabetes-prone; BBR: BioBreeding diabetes-resistant; CFU: Colony-forming units; CLRs: C-type lectin receptors; CREB: CRE binding protein; DAMPS: Damage-associated molecular pattern molecules; FFA: Free fatty acid;…”
BackgroundCani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819 · cited 2×
“Increased intestinal permeability is a result of reduced expression of tight junction proteins, eventually favouring the translocation of bacterial lipopolysaccharide (LPS), which may result in metabolic endotoxemia and insulin resistance [5,6].”
BackgroundToll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 2×
“Studies have shown the intestinal microbiota is associated with the development of metabolic diseases, as obese and diabetic subjects present perturbations in the proportions of Firmicutes, Bacteroidetes and Proteobacterias [4,12].”
BackgroundA microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Round, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233 · cited 1×
“CD4+ and CD8+ T cells are related to the pathogenesis of T1D, once CD4+ may invade pancreatic islets, and CD8+ may initiate β cell destruction [84].”
BackgroundLouis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · cited 2×
“MyD88 knockout mice were protected from developing T1D, and showed lower expression of TNF-α in the pancreatic lymph nodes as compared to wild-type mice [78].”
Ivanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770
Prebiotics: The Concept Revisited1,
Roberfroid, M. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.830s · Cited by 1,498
Developmental microbial ecology of the neonatal gastrointestinal tract
Mackie, R. I., Sghir, A., & Gaskins, H. R. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.5.1035s · Cited by 1,360 · cited 1×
“Mammals present sterile gastrointestinal tract at birth, and their microbiota is gradually accumulated after birth through the physical contact with the breast and the environment [13].”
BackgroundGenetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265 · cited 1×
“Type 1 diabetes results from autoimmune destruction of pancreatic β cells in genetically predisposed individuals [53].”
BackgroundGut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects
Radilla-Vázquez, R. B., Parra-Rojas, I., Martínez-Hernández, N. E., Márquez-Sandoval, Y. F., Illades-Aguiar, B., & Castro-Alarcón, N. (2016) · Obesity Facts · doi:10.1159/000442479 · Cited by 1,196
Toll-like receptors and innate immunity
Kumar, H., Kawai, T., & Akira, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.062 · Cited by 1,173
Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss
Furet, J.-P., Kong, L.-C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.-L., Mariat, D., Corthier, G., Doré, J., Henegar, C., et al. (2010) · Diabetes · doi:10.2337/db10-0253 · Cited by 1,173 · cited 1×
“Diabetic individuals have lower counts of Bifidobacterium and Faecalibacterium prausnitzii, both of them Gram+ [26] with anti-inflammatory properties [26,27].”
BackgroundTHE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113 · cited 1×
“Some epidemiological evidence – such as declined incidence of T1D in Caucasian Europeans, increased incidence in children under five in some demographic areas such as North America, Australia and North Africa, as well as T1D discordance in monozygotic twins – suggests the contribution of environmental factors for the…”
BackgroundCreely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., Evans, M., Harte, A. L., & Kumar, S. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00302.2006 · Cited by 1,043 · cited 1×
“The relationship between LPS and the development of T2D has been observed in some clinical trials [29-33].”
BackgroundIncidence of diabetes in youth in the United States
SEARCH for Diabetes in Youth Study Group*, T. W. G. F. T. (2007) · JAMA · doi:10.1001/jama.297.24.2716 · Cited by 991 · cited 1×
“β cell destruction involves innate and adaptive immune responses, and when around 80% of the β cells are affected, the first signs of diabetes become manifested [54].”
BackgroundThe role of the gut microbiota in energy metabolism and metabolic disease
Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974 · cited 1×
“Intestinal microbiota modulation by probiotics appears to offer beneficial outcomes to insulin-resistant individuals via mechanisms both related and unrelated to inflammation [115].”
Backgroundde La Serre, C. B., Ellis, C. L., Lee, J., Hartman, A. L., Rutledge, J. C., & Raybould, H. E. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00098.2010 · Cited by 949 · cited 1×
“Diet is pivotal for regulation of the intestinal microbiota, excess of nutrients like saturated [16] and polyunsaturated fatty acids [17] or shortage of oligosaccharides [18,19] and phytochemicals [20] can modify the bacterial metabolic activity [21].”
BackgroundIntestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses
Geuking, M. B., Cahenzli, J., Lawson, M. A. E., Ng, D. C. K., Slack, E., Hapfelmeier, S., McCoy, K. D., & Macpherson, A. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.021 · Cited by 840 · cited 3×
“[86] proposes this mutualistic response to be related to a variety of regulatory T cell subsets in a complex real-life gut flora, inclusive of symbiotic, commensal with the potential to become pathogenic, and pathogenic microorganisms.”
BackgroundAmar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermúdez‐Humarán, L. G., Smirnova, N., Bergé, M., Sulpice, T., Lahtinen, S., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100159 · Cited by 836
Toward defining the autoimmune microbiome for type 1 diabetes
Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Novelo, L. L., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.92 · Cited by 806
Probiotic bacteria and intestinal epithelial barrier function
Ohland, C. L., & MacNaughton, W. K. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00243.2009 · Cited by 801
Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025792 · Cited by 778 · cited 1×
“In another study, the gut microbiota composition of T1D children showed increased virulence factors, phage, prophage, motility genes and higher response to stress [74].”
Murri, M., Leiva, I., Gomez-Zumaquero, J. M., Tinahones, F. J., Cardona, F., Soriguer, F., & Queipo-Ortuño, M. I. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-46 · Cited by 765
Role of Toll-Like Receptors in Infection and Immunity: Clinical Implications
Cristofaro, P. A., & Opal, S. M. (2006) · Drugs · doi:10.2165/00003495-200666010-00002 · Cited by 708
The immune system and the gut microbiota: friends or foes?
Cerf-Bensussan, N., & Gaboriau-Routhiau, V. (2010) · Nature Reviews Immunology · doi:10.1038/nri2850 · Cited by 704 · cited 1×
“The alterations observed in BB rats may be due to limited functioning of their immune system [72]; however, this causal relationship remains under investigation.”
BackgroundThe endocannabinoid system links gut microbiota to adipogenesis
Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. M., & Cani, P. D. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.46 · Cited by 691
Probiotic yogurt improves antioxidant status in type 2 diabetic patients
Ejtahed, H. S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., & Mofid, V. (2012) · Nutrition · doi:10.1016/j.nut.2011.08.013 · Cited by 683
(S)NO Signals: Translocation, Regulation, and a Consensus Motif
Stamler, J. S., Toone, E. J., Lipton, S. A., & Sucher, N. J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80310-4 · Cited by 681
Karczewski, J., Troost, F. J., Konings, I., Dekker, J., Kleerebezem, M., Brummer, R.-J. M., & Wells, J. M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00327.2009 · Cited by 676 · cited 2×
“Accumulation of these proteins is associated with increased protection at intestinal barrier level [120], and the organization of these occlusion proteins may occur via activation of TLR2 receptors on the apical surface of the intestinal epithelium [119].”
BackgroundHigh-throughput diversity and functionality analysis of the gastrointestinal tract microbiota
Zoetendal, E. G., Rajilić-Stojanović, M., & de Vos, W. M. (2008) · Gut · doi:10.1136/gut.2007.133603 · Cited by 673
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670 · cited 1×
“Eventually, peripheral tissues exposed to chronic compensatory hyperinsulinemia become resistant to insulin [11].”
BackgroundBurger-van Paassen, N., Vincent, A., Puiman, P. J., van der Sluis, M., Bouma, J., Boehm, G., van Goudoever, J. B., van Seuningen, I., & Renes, I. B. (2009) · Biochemical Journal · doi:10.1042/bj20082222 · Cited by 611
Lam, Y. Y., Ha, C. W. Y., Campbell, C. R., Mitchell, A. J., Dinudom, A., Oscarsson, J., Cook, D. I., Hunt, N. H., Caterson, I. D., Holmes, A. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034233 · Cited by 604 · cited 1×
“T1D patients show perturbations in the structure of tight junctions as result of decreased zonulin expression, a protein related to the regulation of intestinal permeability [61], as well as increased paracellular space between intestinal epithelial cells [6].”
BackgroundYadav, H., Jain, S., & Sinha, P. R. (2007) · Nutrition · doi:10.1016/j.nut.2006.09.002 · Cited by 587
Epithelial crosstalk at the microbiota–mucosal interface
Wells, J. M., Rossi, O., Meijerink, M., & van Baarlen, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000092107 · Cited by 579
Toll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice†
Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S. C., & Bergheim, I. (2009) · Hepatology · doi:10.1002/hep.23122 · Cited by 562
Fecal Microbiota Composition Differs Between Children With β-Cell Autoimmunity and Those Without
de Goffau, M. C., Luopajärvi, K., Knip, M., Ilonen, J., Ruohtula, T., Härkönen, T., Orivuori, L., Hakala, S., Welling, G. W., Harmsen, H. J., et al. (2013) · Diabetes · doi:10.2337/db12-0526 · Cited by 557
Understanding the role of gut microbiome–host metabolic signal disruption in health and disease
Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.05.006 · Cited by 541 · cited 1×
“cardiovascular diseases and dyslipidaemia [3,4].”
The “Perfect Storm” for Type 1 Diabetes
Vaarala, O., Atkinson, M. A., & Neu, J. (2008) · Diabetes · doi:10.2337/db08-0331 · Cited by 497
Ghanim, H., Abuaysheh, S., Sia, C. L., Korzeniewski, K., Chaudhuri, A., Fernandez-Real, J. M., & Dandona, P. (2009) · Diabetes Care · doi:10.2337/dc09-0979 · Cited by 494
Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis
Drucker, D. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0306 · Cited by 483
Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia
Hall, D. M., Buettner, G. R., Oberley, L. W., Xu, L., Matthes, R. D., & Gisolfi, C. V. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.2.h509 · Cited by 461
Increased intestinal permeability precedes clinical onset of type 1 diabetes
Bosi, E., Molteni, L., Radaelli, M. G., Folini, L., Fermo, I., Bazzigaluppi, E., Piemonti, L., Pastore, M. R., & Paroni, R. (2006) · Diabetologia · doi:10.1007/s00125-006-0465-3 · Cited by 443
Enterocyte TLR4 Mediates Phagocytosis and Translocation of Bacteria Across the Intestinal Barrier
Neal, M. D., Leaphart, C., Levy, R., Prince, J., Billiar, T. R., Watkins, S., Li, J., Cetin, S., Ford, H., Schreiber, A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3070 · Cited by 433
Kriegel, M. A., Sefik, E., Hill, J. A., Wu, H.-J., Benoist, C., & Mathis, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108924108 · Cited by 423
Ma, X., Hua, J., & Li, Z. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.05.025 · Cited by 415
Endotoxemia Is Associated With an Increased Risk of Incident Diabetes
Pussinen, P. J., Havulinna, A. S., Lehto, M., Sundvall, J., & Salomaa, V. (2011) · Diabetes Care · doi:10.2337/dc10-1676 · Cited by 406
Selection and Characterisation of Lactobacillus and Bifidobacterium Strains for Use as Probiotics
Prasad, J., Gill, H., Smart, J., & Gopal, P. K. (1998) · International Dairy Journal · doi:10.1016/s0958-6946(99)00024-2 · Cited by 389
Shoaf, K., Mulvey, G. L., Armstrong, G. D., & Hutkins, R. W. (2006) · Infection and Immunity · doi:10.1128/iai.01030-06 · Cited by 385
Luoto, R., Laitinen, K., Nermes, M., & Isolauri, E. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509993898 · Cited by 367
Martin‐Orozco, N., Chung, Y., Chang, S. H., Wang, Y., & Dong, C. (2009) · European Journal of Immunology · doi:10.1002/eji.200838475 · Cited by 359
Calcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonato, V., Marzotti, S., Corneli, R. B., Ferretti, E., Gulino, A., Grasso, F., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1831-2 · Cited by 352
Experimental Endotoxemia Induces Adipose Inflammation and Insulin Resistance in Humans
Mehta, N. N., McGillicuddy, F. C., Anderson, P. D., Hinkle, C. C., Shah, R., Pruscino, L., Tabita-Martinez, J., Sellers, K. F., Rickels, M. R., & Reilly, M. P. (2010) · Diabetes · doi:10.2337/db09-0367 · Cited by 348
Andreasen, A. S., Larsen, N., Pedersen-Skovsgaard, T., Berg, R. M. G., Møller, K., Svendsen, K. D., Jakobsen, M., & Pedersen, B. K. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510002874 · Cited by 347
Itoh, N., Hanafusa, T., Miyazaki, A., Miyagawa, J., Yamagata, K., Yamamoto, K., Waguri, M., Imagawa, A., Tamura, S., & Inada, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116835 · Cited by 346
Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate†
Lewis, K., Lutgendorff, F., Phan, V., Söderholm, J. D., Sherman, P. M., & McKay, D. M. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21177 · Cited by 335
Microbes, immunoregulation, and the gut: Figure 1
Rook, G. A. W., & Brunet, L. R. (2005) · Gut · doi:10.1136/gut.2004.053785 · Cited by 334
Brugman, S., Klatter, F. A., Visser, J. T. J., Wildeboer-Veloo, A. C. M., Harmsen, H. J. M., Rozing, J., & Bos, N. A. (2006) · Diabetologia · doi:10.1007/s00125-006-0334-0 · Cited by 332
Gut microflora as a target for energy and metabolic homeostasis
Cani, P. D., & Delzenne, N. M. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3282efdebb · Cited by 332 · cited 1×
“Such effect leads to higher concentrations of pro-inflammatory cytokines in various tissues via TLR4 activation [42,5,43].”
BackgroundToll-like receptors: linking inflammation to metabolism
Könner, A. C., & Brüning, J. C. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.08.007 · Cited by 331
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept
for the D.E.S.I.R. Study Group, Amar, J., Serino, M., Lange, C., Chabo, C., Iacovoni, J., Mondot, S., Lepage, P., Klopp, C., Mariette, J., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2329-8 · Cited by 327
Laitinen, K., Poussa, T., Isolauri, E., & the Nutrition, A. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508111461 · Cited by 308
Lactobacillus johnsonii N6.2 Mitigates the Development of Type 1 Diabetes in BB-DP Rats
Valladares, R., Sankar, D., Li, N., Williams, E., Lai, K.-K., Abdelgeliel, A. S., Gonzalez, C. F., Wasserfall, C. H., Larkin, J., Schatz, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010507 · Cited by 279
Moroti, C., Souza Magri, L. F., de Rezende Costa, M., Cavallini, D. C., & Sivieri, K. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-29 · Cited by 254
Foulis, A. K., Farquharson, M. A., & Hardman, R. (1987) · Diabetologia · doi:10.1007/bf00299027 · Cited by 248
Kim, J. J., & Sears, D. D. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/212563 · Cited by 248
Roesch, L. F. W., Lorca, G. L., Casella, G., Giongo, A., Naranjo, A., Pionzio, A. M., Li, N., Mai, V., Wasserfall, C. H., Schatz, D., et al. (2009) · The ISME Journal · doi:10.1038/ismej.2009.5 · Cited by 242
The influence of polyunsaturated fatty acids on probiotic growth and adhesion
Kankaanpää, P. (2001) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(00)00519-x · Cited by 237
Lactobacillus fermentum ME-3 – an antimicrobial and antioxidative probiotic
Mikelsaar, M., & Zilmer, M. (2009) · Microbial Ecology in Health and Disease · doi:10.1080/08910600902815561 · Cited by 225
Akashi-Takamura, S., & Miyake, K. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.07.001 · Cited by 213
Yadav, H., Jain, S., & Sinha, P. R. (2008) · Journal of Dairy Research · doi:10.1017/s0022029908003129 · Cited by 211
Probiotics, Immunomodulation, and Health Benefits
Gill, H., & Prasad, J. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74087-4_17 · Cited by 210
Beta cell apoptosis in diabetes
Thomas, H. E., McKenzie, M. D., Angstetra, E., Campbell, P. D., & Kay, T. W. (2009) · Apoptosis · doi:10.1007/s10495-009-0339-5 · Cited by 205
Cani, P. D., Daubioul, C. A., Reusens, B., Remacle, C., Catillon, G., & Delzenne, N. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06100 · Cited by 197
Secondulfo, M., Iafusco, D., Carratù, R., deMagistris, L., Sapone, A., Generoso, M., Mezzogiorno, A., Sasso, F. C., Cartenı̀, M., De Rosa, R., et al. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2003.09.016 · Cited by 192
Gooding, J. M., Yap, K. L., & Ikura, M. (2004) · BioEssays · doi:10.1002/bies.20033 · Cited by 187
Influence of microbial environment on autoimmunity
Chervonsky, A. V. (2009) · Nature Immunology · doi:10.1038/ni.1801 · Cited by 185
Vaarala, O., Knip, M., Paronen, J., Hämäläinen, A. M., Muona, P., Väätäinen, M., Ilonen, J., Simell, O., & Akerblom, H. K. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1389 · Cited by 182 · cited 1×
“Bovine insulin for example, which can be found in cow’s milk, appears to sensitize intestinal T lymphocytes in susceptible children, which in turn could participate in the autoimmune destruction of pancreatic β cells [65].”
BackgroundMolecular Targets Related to Inflammation and Insulin Resistance and Potential Interventions
Hirabara, S. M., Gorjão, R., Vinolo, M. A., Rodrigues, A. C., Nachbar, R. T., & Curi, R. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/379024 · Cited by 178
The changing epidemiology of type 1 diabetes: why is it going through the roof?
Vehik, K., & Dabelea, D. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1141 · Cited by 175
Chen, J., Wang, R., Li, X.-F., & Wang, R.-L. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511004491 · Cited by 169
Neu, J., Reverte, C. M., Mackey, A. D., Liboni, K., Tuhacek‐Tenace, L. M., Hatch, M., Li, N., Caicedo, R. A., Schatz, D. A., & Atkinson, M. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000159636.19346.c1 · Cited by 160
Inhibition of Type 1 Diabetes Correlated to a Lactobacillus johnsonii N6.2-Mediated Th17 Bias
Lau, K., Benitez, P., Ardissone, A., Wilson, T. D., Collins, E. L., Lorca, G., Li, N., Sankar, D., Wasserfall, C., Neu, J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001864 · Cited by 158
Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies
Al-Attas, O. S., Al-Daghri, N. M., Al-Rubeaan, K., da Silva, N. F., Sabico, S. L., Kumar, S., McTernan, P. G., & Harte, A. L. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-20 · Cited by 145
Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance
Sugita, H., Kaneki, M., Tokunaga, E., Sugita, M., Koike, C., Yasuhara, S., Tompkins, R. G., & Martyn, J. A. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00087.2001 · Cited by 129
Hummel, S., Veltman, K., Cichon, C., Sonnenborn, U., & Schmidt, M. A. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.06983-11 · Cited by 126
SERREZE, D. V., Post, C. M., Chapman, H. D., Johnson, E. A., Lu, B., & Rothman, P. B. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2007 · Cited by 122
Ohkawara, S., Furuya, H., Nagashima, K., Asanuma, N., & Hino, T. (2005) · Journal of Nutrition · doi:10.1093/jn/135.12.2878 · Cited by 122
Polyphenolic Compounds: Interactions with the Gut and Implications for Human Health
Gee, J., & Johnson, I. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372256 · Cited by 120
Mencarelli, A., Cipriani, S., Renga, B., Bruno, A., D'Amore, C., Distrutti, E., & Fiorucci, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045425 · Cited by 116
Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse
Andersson, U., Bränning, C., Ahrné, S., Molin, G., Alenfall, J., Önning, G., Nyman, M., & Holm, C. (2010) · Beneficial Microbes · doi:10.3920/bm2009.0036 · Cited by 115
Seewaldt, S., Thomas, H. E., Ejrnaes, M., Christen, U., Wolfe, T., Rodrigo, E., Coon, B., Michelsen, B., Kay, T. W., & von Herrath, M. G. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1801 · Cited by 111
Prevention of Virus-Induced Type 1 Diabetes with Antibiotic Therapy
Hara, N., Alkanani, A. K., Ir, D., Robertson, C. E., Wagner, B. D., Frank, D. N., & Zipris, D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201257 · Cited by 107
Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1
Hiratani, K., Haruta, T., Tani, A., Kawahara, J., Usui, I., & Kobayashi, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.152 · Cited by 101
Atkinson, M. A., & Chervonsky, A. (2012) · Diabetologia · doi:10.1007/s00125-012-2672-4 · Cited by 91
Kingma, S. D. K., Li, N., Sun, F. F., Valladares, R. B., Neu, J., & Lorca, G. L. (2011) · Journal of Nutrition · doi:10.3945/jn.110.135517 · Cited by 91
Shinozaki, S., Choi, C. S., Shimizu, N., Yamada, M., Kim, M., Zhang, T., Shiota, G., Dong, H. H., Kim, Y.-B., & Kaneki, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187666 · Cited by 90
Effect of ischemia on intestinal permeability of lipopolysaccharides
Drewe, J., Beglinger, C., & Fricker, G. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00792.x · Cited by 77
Intestinal microflora and metabolic diseases
Serino, M., Luche, E., Chabo, C., Amar, J., & Burcelin, R. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.03.003 · Cited by 77 · cited 1×
“Diet is pivotal for regulation of the intestinal microbiota, excess of nutrients like saturated [16] and polyunsaturated fatty acids [17] or shortage of oligosaccharides [18,19] and phytochemicals [20] can modify the bacterial metabolic activity [21].”
BackgroundAutoimmune disease in the era of the metagenome
Proal, A. D., Albert, P. J., & Marshall, T. G. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.02.016 · Cited by 72
AMP-18 protects barrier function of colonic epithelial cells: role of tight junction proteins
Walsh-Reitz, M. M., Huang, E. F., Musch, M. W., Chang, E. B., Martin, T. E., Kartha, S., & Toback, F. G. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00013.2005 · Cited by 68
Increased Adipocyte S-Nitrosylation Targets Anti-lipolytic Action of Insulin
Ovadia, H., Haim, Y., Nov, O., Almog, O., Kovsan, J., Bashan, N., Benhar, M., & Rudich, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.235945 · Cited by 64
Action of reactive oxygen species on colonic mucus secretions
Brownlee, I. A., Knight, J. L., Dettmar, P. W., & Pearson, J. P. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.023 · Cited by 61
Jabri, B., & Ebert, E. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00481.x · Cited by 57
Effect of Lactobacillus reuteri GMNL-263 treatment on renal fibrosis in diabetic rats
Lu, Y.-C., Yin, L., Chang, W., & Huang, J. (2010) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2010.07.006 · Cited by 53
Use of Probiotics in Humans: An Analysis of the Literature
Floch, M. H., & Montrose, D. C. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.05.004 · Cited by 50
Tiittanen, M., Huupponen, J. T., Knip, M., & Vaarala, O. (2006) · Diabetes · doi:10.2337/db06-0132 · Cited by 48
The Intestinal Microbiome: Relationship to Type 1 Diabetes
Neu, J., Lorca, G. L., Kingma, S. D. K., & Triplett, E. W. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.008 · Cited by 46
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo
O'Mahony, D., Murphy, S., Boileau, T. W.-M., Park, J., O'Brien, F., Groeger, D., Konieczna, P., Ziegler, M., Scully, P., Shanahan, F., et al. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-63 · Cited by 45
PKC-δ binds to E-cadherin and mediates EGF-induced cell scattering
Singh, R., Lei, P., & Andreadis, S. T. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.07.002 · Cited by 41
Dixon, A., Valsamakis, G., Hanif, M. W., Field, A., Boutsiadis, A., Harte, A. L., McTernan, P. G., Barnett, A. H., & Kumar, S. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01800.x · Cited by 38
Yadav, H., Jain, S., & Sinha, P. R. (2008) · Journal of Medicinal Food · doi:10.1089/jmf.2006.136 · Cited by 36
Engst, R. (1976) · Food / Nahrung · doi:10.1002/food.19760200630 · Cited by 32
Anti-inflammatory Mechanism ofLactobacillus rhamnosus GGin Lipopolysaccharide-stimulated HT-29 Cell
Lee, S. K., Yang, K. M., Cheon, J. H., Kim, T. I., & Kim, W. H. (2012) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2012.60.2.86 · Cited by 29
Application of HPLC in Disposition Study of A14-125I-Labeled Insulin in Mice
Sato, H., Tsuji, A., Hirai, K., & Kang, Y. S. (1990) · Diabetes · doi:10.2337/diab.39.5.563 · Cited by 19
W1844 Bifidobacterium Animalis Ahc7 Protects Against Pathogen-Induced NF-κB Activation In Vivo
O'Mahony, D., Murphy, S., O'Brien, F., Groeger, D., Boileau, T. W.-M., Kiely, B., Shanahan, F., & O’Mahony, L. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)63464-6 · Cited by 7
Research works printed but not linked: 2
- WHO - World Health Organization World Health Statistics WHO/FAO 2012 Geneva: WHO
- WHO - World Health Organization Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria Joint WHO/FAO Expert Consultation on Geneva 2001 Cordoba, Argentina: WHO
Cited by
Antioxidant Properties of Probiotic Bacteria
Wang, Y., Wu, Y., Wang, Y., Xu, H., Mei, X., Yu, D., Wang, Y., & Li, W. (2017) · Nutrients · doi:10.3390/nu9050521 · Cited by 917
The human gut microbiota: Metabolism and perspective in obesity
Gomes, A. C., Hoffmann, C., & Mota, J. F. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1465157 · Cited by 727
Self-citationMilk kefir : nutritional, microbiological and health benefits
Rosa, D. D., Dias, M. M. S., Grześkowiak, Ł. M., Reis, S. A., Conceição, L. L., & Peluzio, M. D. C. G. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422416000275 · Cited by 463
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
Zhang, Y., Gu, Y., Ren, H., Wang, S., Zhong, H., Zhao, X., Ma, J., Gu, X., Xue, Y., Huang, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18414-8 · Cited by 380
Precup, G., & Vodnar, D.-C. (2019) · British Journal of Nutrition · doi:10.1017/s0007114519000680 · Cited by 378
“microbiota are represented by two phyla, Firmicutes (which includes mainly Clostridium, Enterococcus, Lactobacillus and Faecalibacterium genera) and Bacteroidetes (which includes notably Bacteroides and Prevotella genera)(5,10).”
Background
Metadata
- Authors
- Gomes, A. C., Bueno, A. A., de Souza, R. G. M., & Mota, J. F.
- Affiliations
- Universidade Federal de Goiás (BR)
- University of Worcester (GB)
- Corresponding author
- Mota, João Felipe
- Venue
- Nutrition Journal
- Published
- 2014-06-17
- Volume
- 13
- Issue
- 1
- Pages
- 60-60
- ISSN
- 1475-2891 (ISSN-L)
- PMC
- PMC4078018
- OpenAlex
- W2125446896
- Cited by
- 363
- References
- 124
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 33 · 2023: 34 · 2022: 44 · 2021: 39 · 2020: 41 · 2019: 35 · 2018: 32 · 2017: 28 · 2016: 26 · 2015: 20 · 2014: 1
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrition Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- Worcester Research and Publications (University of Worcester) (acceptedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- University of Worcester
- Fundação de Amparo à Pesquisa do Estado de Goiás
- Universidade de São Paulo
- Universidade Estadual Paulista
- Directorate for Biological Sciences
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, probiotics, type 2 diabetes, type 1 diabetes, insulin sensitivity, intestinal inflammation, oxidative stress, intestinal permeability, islet autoimmunity, IL-17, IRS-1, diabetes prevention
- MeSH terms
- Animals, Clinical Trials as Topic, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Inflammation, Insulin Resistance, Probiotics, Gastrointestinal Tract, Toll-Like Receptor 4, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.